Feeder-Free iPSC Culture Platform for Single-Cell Sorting

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for generating induced pluripotent stem cells (iPSCs) face challenges such as genomic instability, low efficiency, and the need for extensive manual screening due to the use of integrating viral systems, leading to potential insertional mutagenesis and variability in gene expression, as well as inefficiencies in identifying and maintaining pluripotency.

Innovation Solution

A feeder-free culture method using a combination of TGFβ, GSK3, MEK, and Rock inhibitors, along with specific small molecule agents like SB431542, CHIR99021, PD0325901, and thiazovivin, to maintain and enhance pluripotency, viability, and efficiency of iPSC generation and differentiation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If integrating viral systems are used to express key transcription factors for iPSC generation, then reprogramming efficiency is improved, but genomic stability deteriorates due to insertional mutagenesis

Engineering Contradiction:
Improvereprogramming efficiencyVSAvoidgenomic stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent extracts and removes the integrating viral systems from the reprogramming process. Instead of using retroviral or lentiviral vectors that integrate into the genome, the invention employs non-integrating methods such as episomal plasmids or protein transduction, thereby eliminating insertional mutagenesis while maintaining reprogramming efficiency

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs transient, non-integrating reprogramming methods that leave no permanent genomic footprint. Episomal plasmids are lost after replication, and protein-based reprogramming factors are degraded after performing their function, ensuring genomic stability without requiring long-term viral integration

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Measurement precision

If manual screening methods are used to identify pluripotent cells, then identification accuracy is improved, but time consumption increases

Engineering Contradiction:
Improveidentification accuracyVSAvoidtime consumption
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent employs fluorescently labeled antibodies that bind to pluripotency markers (such as SSEA-4, TRA-1-60, TRA-1-81) on cell surfaces. These fluorescent labels enable rapid identification and sorting of pluripotent cells using flow cytometry or fluorescence-activated cell sorting (FACS), replacing slow manual screening with automated optical detection

Inventive Principle:
Principle #32Color changes

Solution Approach 2:

The patent replaces manual mechanical screening methods with automated flow cytometry and FACS systems. These automated systems use optical detection and hydrodynamic focusing to rapidly analyze and sort thousands of cells per second based on fluorescent marker expression, dramatically reducing time while maintaining high accuracy

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If feeder cells are used in culture, then cell viability is improved, but contamination risk increases

Engineering Contradiction:
Improvecell viabilityVSAvoidcontamination risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and removes feeder cells from the culture system. Instead of using irradiated or mitomycin C-treated fibroblasts as feeder layers, the invention employs feeder-free culture conditions with defined extracellular matrix coatings (such as laminin-521 or matrigel) and optimized culture media containing small molecule inhibitors (like ROCK inhibitors) to maintain cell viability and pluripotency without cellular feeders

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent replaces long-lived feeder cell layers with disposable, acellular extracellular matrix coatings. These coated surfaces provide necessary attachment and signaling functions temporarily during culture, without the risk of feeder cell contamination or variability, and can be easily replaced between experiments

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

4Reliability

If extensive cloning is performed to identify stable iPSC clones, then clone stability is improved, but productivity decreases

Engineering Contradiction:
Improveclone stabilityVSAvoidderivation speed
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent performs preliminary selection of high-quality reprogramming clones early in the process using flow cytometry-based sorting of pluripotency marker-positive cells. This preliminary action enriches the population for stable, pluripotent clones before expansion, reducing the need for extensive subsequent screening and cloning while ensuring clone stability from the outset

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent implements feedback mechanisms where early characterization data (pluripotency marker expression, karyotype analysis, differentiation potential) guide subsequent expansion and validation decisions. This feedback-driven approach allows rapid identification and expansion of stable clones without exhaustive screening of all generated clones, improving both speed and reliability

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS20260035672A1Cell culture platform for single cell sorting and enhanced reprogramming of ipscs
Publication Date: 2026.02.05 FATE THERAPEUTICS INC
  • US20260035672A1 patent drawing
  • US20260035672A1 patent drawing
  • US20260035672A1 patent drawing

AI summary

The invention provides cell culture conditions for culturing stem cells, including feeder-free conditions for generating and culturing human induced pluripotent stem cells (iPSCs). More particularly, the invention provides a culture platform that allows long-term culture of pluripotent cells in a feeder-free environment; reprogramming of cells in a feeder-free environment; single-cell dissociation of pluripotent cells; cell sorting of pluripotent cells; maintenance of an undifferentiated status; improved efficiency of reprogramming; and generation of a naïve pluripotent cell.